Clover Health Downgraded to Underperform From Neutral At BofA
June 10, 2021 at 08:26 AM EDT
BofA analyst Kevin Fischbeck downgraded Clover Health Investments to Underperform from Neutral with an unchanged price target of $10.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.